Kmart Launches National Influenza Vaccine Program in Partnership with ASB Meditest

Strategic Insights -

Kmart Corporation, a leading American retail chain, has announced a national influenza vaccine program for its customers across the United States. In partnership with ASB Meditest, a leading provider of occupational health services, Kmart will administer flu shots at participating locations nationwide during October and November. The program aims to encourage all adults, particularly those in high-risk categories, to update their immunizations against influenza and pneumonia.

Key Takeaways:

  • The program will offer flu shots, as well as pneumonia and tetanus/diphtheria vaccinations, at a nominal fee of $10 for flu shots and $20 for additional vaccinations.
  • Kmart pharmacists will work with patients and their family doctors to provide quality health care services, including advice on vaccines, prescriptions, and general wellness issues.
  • A portion of the proceeds from the program will be donated to the American Red Cross.
  • The program targets high-risk categories, including individuals over 65 years old, people with heart and lung disease, and those in close contact with many people, such as students, teachers, and healthcare workers.
  • Flu vaccines are recommended for individuals in these categories to reduce their chances of catching the flu.
  • Kmart operates a vast network of 1,657 pharmacies, 2,163 retail outlets, and 171 Builders Square stores across the United States and internationally.

Statistics:

  • The program aims to offer vaccinations at participating Kmart locations nationwide.
  • The flu vaccine is recommended for individuals over 65 years old and those in high-risk categories.
  • A portion of the proceeds will be donated to the American Red Cross.

Sources:

  • Kmart Corporation (NYSE: KM)
  • ASB Meditest
  • American Red Cross
  • US News & World Report